Recently, there has been confusion for international travelers looking to protect themselves from dengue disease, which is transmitted to people by mosquitoes.
In January 2024, Sanofi-Pasteur announced that they would stop manufacturing the U.S. FDA-approved Dengvaxia® vaccine for children due to a lack of demand in the global market.
Read More
